Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program
Clinical trial NCT06253637 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06253637
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-17
- Primary completion
- 2029-10-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.